CR MEDICAL (01515) Reports Interim Results with Shareholder Attributable Profit of RMB 340 Million, Down 21.76% Year-on-Year

Stock News
Aug 26

CR MEDICAL (01515) announced its interim results for the six months ended June 30, 2025, reporting revenue of RMB 4.525 billion, representing a year-on-year decrease of 9.07%. Shareholder attributable profit reached RMB 340 million, declining 21.76% compared to the same period last year. Basic earnings per share stood at RMB 0.27, with the company proposing an interim dividend of 5 cents per share.

According to the announcement, during the reporting period, the hospital business segment generated revenue of RMB 4.259 billion, down 7.4% year-on-year. Outpatient and emergency visits increased by 1.0%, while inpatient admissions decreased by 3.9%. Due to reduced medical insurance reimbursement rates, average revenue per outpatient visit and per inpatient stay both declined by 5.8%.

As of June 30, 2025, the group operates and manages 103 medical institutions across 10 provinces and cities in China. During the reporting period, the group's hospitals handled approximately 5.1 million outpatient and emergency visits and 270,000 inpatient admissions, representing increases of 1.0% and decreases of 3.9% respectively compared to the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10